Author:
Xu Ben,Yuan Chang-wei,Zhang Jia-en
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Complementary and alternative medicine,General Medicine
Reference40 articles.
1. Cao HW, Yu HJ, Feng YG, Chen L, Liang F. Curcumin inhibits prostate cancer by targeting PGK1 in the FOXD3/miR-143 axis. Cancer Chemother Pharmacol 2017;79:985–994.
2. Li JT, Wei HL, Liu YG, Li Q, Guo H, Guo YJ, et al. Curcumin inhibits hepatocellular carcinoma via regulating miR-21/TIMP3 axis. Evid Based Complement Alternat Med 2020;2020:2892917.
3. Liu L, Fu YL, Zheng YY, Ma MK, Wang CH. Curcumin inhibits proteasome activity in triple-negative breast cancer cells through regulating p300/miR-142-3p/ PSMB5 axis. Phytomedicine 2020;78:153312.
4. Zhao SF, Zhang X, Zhang XJ, Shi XQ, Yu ZJ, Kan QC. Induction of microRNA-9 mediates cytotoxicity of curcumin against SKOV3 ovarian cancer cells. Asian Pac J Cancer Prev 2014;15:3363–3368.
5. Sun CL, Zhang SP, Liu CH, Liu XQ. Curcumin promoted miR-34a expression and suppressed proliferation of gastric cancer cells. Cancer Biother Radiopharm 2019;34:634–641.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献